Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lubov Sorokina"'
Autor:
Mikhail Kostik, Elvira Kalashnikova, Raupov Rinat, Eugenia Isupova, Ekaterina Gaidar, Anton A. Soloviev, Vera Masalova, Ludmila Snegireva, Tatyana Kornishina, Natalia Abramova, Evgeny Suspitsin, Lubov Sorokina, Maria Kaneva, Margarita F. Dubko, Natalia Lubimova, Ekaterina Kuchuinskaya, Olga Kalashnikova, Vyacheslav Chasnyk
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1503 (2023)
Background: Pediatric lupus nephritis (LN) is one of the most serious manifestations of systemic lupus erythematosus (SLE) in children, determining the outcomes of the disease. There are no standardized treatment protocols for pediatric LN, and the r
Externí odkaz:
https://doaj.org/article/187687cddb6f48418e0a778141183cd7
Publikováno v:
Bone Reports, Vol 14, Iss , Pp 100940- (2021)
Externí odkaz:
https://doaj.org/article/1a4639a0f9c847c5b5b6e0d41efa387c
Autor:
V. Masalova, Lubov Sorokina, Ilia Avrusin, M. Kostik, T. Likhacheva, I.A. Chikova, M. Gharabaghtsyan, R. Raupov, E. Gaidar, L. Snegireva, S. Khrypov, M. Dubko, N. Garipova, E. Isupova
Publikováno v:
Annals of the Rheumatic Diseases. 80:931-932
Background:Hip osteoarthritis (HOA) is a severe outcome of juvenile idiopathic arthritis (JIA) itself and also can be result of corticosteroid (CS) treatment, if it was used. Total hip arthroplasty (THA) is the last step in JIA treatment and indicate
Autor:
V. Argunova, M. Kostik, T. Bourtseva, F. Vinokurova, Vyacheslav Chasnyk, Lubov Sorokina, P. Sleptsova
Publikováno v:
Annals of the Rheumatic Diseases. 80:930.1-930
Background:Sakha Republic (Yakutia) - SR(Y) is a bid arctic region of Russia with high proportion of aboriginals - Yakutians (50%), intra-national marriages, increased level of inbreeding and high distribution of HLAB27 among aboriginals – 33%, acc
Autor:
R. Raupov, V. Masalova, Evgeny N. Suspitsin, Vyacheslav Chasnyk, Lubov Sorokina, T. Ermachenkova, T. Likhacheva, M. Kostik, Olga Kalashnikova, T. Gabrusskaya, E. Gaidar, M. Dubko, L. Snegireva, E. Isupova, M. Kaneva
Publikováno v:
Annals of the Rheumatic Diseases. 80:247.1-248
Background:While efficacy of tofacitinib (TOF) has been proven in many adult immune-mediated conditions, the information on its’ safety and efficacy in the pediatric population is limited.Objectives:to evaluate the safety and efficacy of TOF in chi
Autor:
Tatiana Likhacheva, Ilya Avrusin, E. Isupova, E. Gaidar, Elizaveta Orlova, Lubov Sorokina, Olga Kalashnikova, V. Masalova, Yuri Korin, M. Dubko, Tatiana Kornishina, L. Snegireva, R. Raupov, Mikhail Kostik
Publikováno v:
Abstracts Accepted for Publication.
Background Methotrexate (MTX) is a gold standard for treatment of juvenile idiopathic arthritis (JIA) patients. The main adverse events (AE) related to the MTX are intolerance, increased rate of infections, elevation of the liver enzymes, hematologic
Autor:
Natalia A. Lubimova, Rena Idrisova, Lubov Sorokina, Mikhail Kostik, Olga V. Goleva, Irina V. Fridman, Susanna M. Kharit
Publikováno v:
Poster Presentations.
Background Patients with juvenile idiopathic arthritis (JIA) may have lower protective levels of anti-vaccine antibodies (AVA) due to high inflammatory activity, interrupted or incomplete vaccination schedule, using of immune-modulating drugs, e.g. s
Publikováno v:
Bone Reports, Vol 14, Iss, Pp 100940-(2021)
Autor:
Svitlana V. Khyzhnyak, Volodymyr Voitsitsky, Ludmila I. Stepanova, Dmytro Osynsky, Lubov Sorokina
Publikováno v:
Annales UMCS, Pharmacia. 21:269-271